Filing Details
- Accession Number:
- 0001127602-20-015857
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-07 20:49:14
- Reporting Period:
- 2020-05-05
- Accepted Time:
- 2020-05-07 20:49:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
318154 | Amgen Inc | AMGN | Biological Products, (No Disgnostic Substances) (2836) | 953540776 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1375347 | Sanders R Williams | One Amgen Center Drive Thousand Oaks CA 91320 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-05-05 | 846 | $0.00 | 5,834 | No | 4 | A | Direct | |
Common Stock | Disposition | 2020-05-06 | 425 | $237.31 | 5,409 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.
- The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.